Roy Orlando is a Gastroenterology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 167 publications with 4,693 citations (h-index 39); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 Manning Dr
Chapel Hill, NC 275990001
Telephone
919-843-4583Registry record last updated 1 Apr 2009.
Clinical trials
- Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn
Sponsor: University of North Carolina, Chapel Hill
- Do Acid Sensing Ion Channels Contribute to Heartburn?
Sponsor: University of North Carolina, Chapel Hill
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
4 NIH research awards on record, funded 1986–2014 per NIH RePORTER. The latest:
- Can quercetin increase claudin-4 and improve esophageal barrier function in
Univ of North Carolina Chapel Hill
FY2014$257,264R21DK097529 - ESOPHAGEAL CYTOPROTECTION--AGENTS AND MECHANISMS
Univ of North Carolina Chapel Hill
FY2009$97,853R37DK036013 - ESOPHAGEAL CYTOPROTECTION--AGENTS AND MECHANISMS
Univ of North Carolina Chapel Hill
FY2008$339,164R37DK036013
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2
Infection and Immunity
2015 - Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice
American Journal of Physiology-Gastrointestinal and Liver Physiology
2013 - Safety and Efficacy of Endoscopic Mucosal Therapy With Radiofrequency Ablation for Patients With Neoplastic Barrett's Esophagus
Clinical Gastroenterology and Hepatology
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”